A Database and Biorepository for Mount Sinai Acute Graft-versus-Host Disease International Consortium (MAGIC)

Overview

About this study

The objectives of this study are to prospectively collect hematopoietic stem cell transplantation (HCT) data, complications and outcomes pertinent to graft-versus-host disease from allogeneic HCT patients for future analysis, and to prospectively collect and store blood for future analysis from allogeneic HCT patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients undergoing an allogeneic hematopoietic stem cell transplant.
Patients must have signed the informed consent document

Exclusion Criteria:

Syngeneic donor hematopoietic stem cell transplantation (HCTs) will be excluded.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator William Hogan, M.B., B.Ch.	Open for enrollment	Contact information: Diane Jedlicka (507) 266-8107 Jedlicka.Diane@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

William Hogan, M.B., B.Ch.

Open for enrollment

Contact information:

Diane Jedlicka

(507) 266-8107

Jedlicka.Diane@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials